Results of Lung Cancer CT Screening Show Impact on Death Rates
By MedImaging International staff writers Posted on 01 Aug 2016 |
A new trial has found that lung cancer screening and early detection of lung cancer can prolong the lives of 70% of patients by one year or more.
In addition, the researchers also studied the long-term psychosocial outcomes of Computed Tomography (CT) lung cancer screening and found that screening did not result in unnecessary anxiety. The researchers did find that participants may face barriers such as fear and stigma that prevent their participation in a screening program.
The results of the trial were published in the July 2016 issue of the journal Thorax. The UK Lung cancer Screening trial (UKLS) was led by researchers at Cardiff University (Cardiff, UK), and included more than 4,000 women, and men, between 50 and 75 years old, who had a high risk of contracting lung cancer.
The results of the trial are intended to guide UK clinical and policy decisions for the implementation of potential future low-dose CT lung cancer screening for high-risk patients.
Dr. Kate Brain, Cardiff University, said, "With the UK's five-year survival rate for lung cancer being lower than many other countries with comparable healthcare systems, it is important that we do more to introduce early detection strategies that help to ensure treatment is delivered before patients present at an advanced stage of the disease. Sometimes, fear of medical procedures and the results they might bring can prevent people from seeking life-saving tests. However, what our trial shows is that CT lung cancer screening actually has no long-term negative psychosocial impact on patients, making it an excellent tool for catching lung cancer earlier when there is a better chance of survival."
Related Links:
Cardiff University
In addition, the researchers also studied the long-term psychosocial outcomes of Computed Tomography (CT) lung cancer screening and found that screening did not result in unnecessary anxiety. The researchers did find that participants may face barriers such as fear and stigma that prevent their participation in a screening program.
The results of the trial were published in the July 2016 issue of the journal Thorax. The UK Lung cancer Screening trial (UKLS) was led by researchers at Cardiff University (Cardiff, UK), and included more than 4,000 women, and men, between 50 and 75 years old, who had a high risk of contracting lung cancer.
The results of the trial are intended to guide UK clinical and policy decisions for the implementation of potential future low-dose CT lung cancer screening for high-risk patients.
Dr. Kate Brain, Cardiff University, said, "With the UK's five-year survival rate for lung cancer being lower than many other countries with comparable healthcare systems, it is important that we do more to introduce early detection strategies that help to ensure treatment is delivered before patients present at an advanced stage of the disease. Sometimes, fear of medical procedures and the results they might bring can prevent people from seeking life-saving tests. However, what our trial shows is that CT lung cancer screening actually has no long-term negative psychosocial impact on patients, making it an excellent tool for catching lung cancer earlier when there is a better chance of survival."
Related Links:
Cardiff University
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection